Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues

Tango Therapeutics Inc. (NASDAQ:TNGX) is 1 of the 10 affordable biotech stocks to bargain close now.

On June 29, Canaccord Genuity accrued its people terms connected Tango Therapeutics Inc. (NASDAQ:TNGX) from $42 to $46, resulting successful much than 53% upside potential. The steadfast kept a Buy standing connected the stock, highlighting further upside from vopimetostat + KRAS inhibitors successful NSCLC.

Romaset/Shutterstock.com

The terms people accommodation is based connected a revised valuation exemplary that incorporates combined revenues from the therapy.

Earlier connected June 26, Jefferies upgraded Tango Therapeutics Inc. (NASDAQ:TNGX) from Hold to Buy. The steadfast besides accrued its people terms substantially from $27 to $60, starring to an upside of much than 100% astatine the prevailing level.

Despite a 242% rally truthful acold during 2026, Jefferies anticipates further upside pursuing promising information for vopimetostat positive daraxonrasib. It highlighted that this represents a plausible accidental worthy much than $4 billion, covering astir 25%-40% of patients with pancreatic ductal adenocarcinoma.

During the 2nd week of June, the institution signed an underwriting statement with Leerink Partners and J.P. Morgan Securities for an offering involving astir 18.2 cardinal of the company's communal stock, arsenic good arsenic pre-funded warrants for much than 1.83 cardinal shares.

The communal banal offering was priced astatine $30 per share, portion the warrants were priced astatine $29.99. The institution expects to recognize nett proceeds of astir $566.5 million, which volition beryllium utilized to money pivotal trials, R&D spending, firm needs, and commercialized efforts.

Tango Therapeutics Inc. (NASDAQ:TNGX) is simply a precision oncology institution focusing connected the find and improvement of drugs targeting defined diligent populations with unaddressed objective needs. It develops TNG462, TNG45, and PRMT5 inhibitors for the attraction of pancreatic, lung, and encephalon cancer, respectively. The institution is presently engaged successful the improvement of TNG260 to dainty lung cancer.

While we admit the imaginable of TNGX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.